Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | MYOC | Q99972 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | GRM8 | O00222 | 1/20 | 0.45 |
| ▸ | GRM6 | O15303 | 1/20 | 0.45 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15927423 | 0.87 | TSHR (0.55) | TSHRALDH1A1CYP3A4RECQLLMNA | |
| SCHEMBL16313203 | 0.85 | TSHR (0.53) | TSHRALDH1A1CYP3A4RECQLLMNA | |
| SCHEMBL16959578 | 0.85 | TSHR (0.53) | TSHRALDH1A1CYP3A4RECQLLMNA | |
| SCHEMBL4434685 | 0.85 | ALDH1A1 (0.53) | TSHRALDH1A1CYP3A4RECQLLMNA | |
| SCHEMBL12381771 | 0.85 | MAPT (0.53) | TSHRALDH1A1CYP3A4RECQLLMNA | |
| SCHEMBL4547845 | 0.84 | TSHR (0.55) | TSHRALDH1A1CYP3A4LMNAHSD17B10 | |
| SCHEMBL27859134 | 0.82 | ALDH1A1 (0.50) | TSHRALDH1A1CYP3A4RECQLLMNA | |
| SCHEMBL27859132 | 0.82 | TSHR (0.54) | TSHRALDH1A1CYP3A4RECQLLMNA | |
| SCHEMBL31212652 | 0.81 | TSHR (0.57) | TSHRALDH1A1CYP3A4RECQLLMNA | |
| SCHEMBL20364501 | 0.81 | PDK1 (0.55) | TSHRALDH1A1CYP3A4LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7732534-B2 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2010-06-08 | — | — | US | claimed |
| US-7539006-B2 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2009-05-26 | — | — | US | claimed |
| US-20080051552-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION | 2008-02-28 | — | — | US | claimed |
| US-20070029529-A1 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | KOMATSU AKIHIKO | 2007-02-08 | — | — | US | claimed |
| US-20040245105-A1 | Electrolyte solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2004-12-09 | — | — | US | claimed |
| EP-1437749-A1 | ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | Rubycon Corporation (JP) | 2004-07-14 | — | — | EP | claimed |
| WO-1994010557-A1 | MEMBRANE MANUFACTURING METHOD | PORTON DIAGNOSTICS, INC. (US) | 1994-05-11 | — | — | WO | claimed |
| US-4233136-A | Liquid membrane electrode | NOVA BIOMEDICAL CORPORATION (US) | 1980-11-11 | — | — | US | claimed |
| US-12030876-B2 | Aryl hydrocarbon receptor (AHR) agonists and uses thereof | Ikena Oncology, Inc. (US) | 2024-07-09 | — | — | US | disclosed |
| US-20230339886-A1 | REV-ERB AGONISTS FOR THE TREATMENT OF TH17-MEDIATED INFLAMMATORY DISORDERS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-10-26 | — | — | US | disclosed |
| US-11795174-B2 | Anti-pain compound and preparation method thereof | LUNAN PHARMACEUTICAL GROUP CORPORATION (CN) | 2023-10-24 | — | — | US | disclosed |
| US-20230295147-A1 | ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF | ARYL THERAPEUTICS, INC. | 2023-09-21 | — | — | US | disclosed |
| US-20230276701-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMISSION DEVICE | OSAKA UNIVERSITY (JP) | 2023-08-31 | — | — | US | disclosed |
| US-11712680-B2 | Process for reducing aromatic nitro compounds with supported catalyst | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2023-08-01 | — | — | US | disclosed |
| US-4361473-A | CROWN COMPOUNDS | NOVA BIOMEDICAL CORPORATION (US) | 1982-11-30 | — | — | US | disclosed |
| US-4314895-A | Method of making liquid membrane electrode | NOVA BIOMEDICAL CORPORATION (US) | 1982-02-09 | — | — | US | disclosed |
| US-4303408-A | EXTRACTION ZONE BEFORE INDICATOR ZONE | EASTMAN KODAK COMPANY (US) | 1981-12-01 | — | — | US | disclosed |
| EP-0033707-A1 | Element for liquid analysis having interferent-removal zone and method for using same | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1981-08-12 | — | — | EP | disclosed |
| US-4233136-A | Liquid membrane electrode | NOVA BIOMEDICAL CORPORATION (US) | 1980-11-11 | — | — | US | disclosed |
| US-3976639-A | Intermediates for indoles | HOFFMANN-LA ROCHE INC. (US) | 1976-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339886-A1 | REV-ERB AGONISTS FOR THE TREATMENT OF TH17-MEDIATED INFLAMMATORY DISORDERS | NR1H2, NR1H3, NR1D1 | TSHR 187/4885ALDH1A1 3764/4885CYP3A4 1581/4885 |
| US-11712680-B2 | Process for reducing aromatic nitro compounds with supported catalyst | ARG2, NDUFS5, NDUFS7 | TSHR 2114/4885ALDH1A1 2712/4885CYP3A4 587/4885 |
| US-12030876-B2 | Aryl hydrocarbon receptor (AHR) agonists and uses thereof | AHR, ARNT, HCAR1 | TSHR 156/4885ALDH1A1 289/4885CYP3A4 176/4885 |
| US-20230295147-A1 | ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF | AHR, ARNT, HCAR1 | TSHR 156/4885ALDH1A1 289/4885CYP3A4 176/4885 |
| US-20230276701-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMISSION DEVICE | ESR1, ECE1, ESYT1 | TSHR 3456/4885ALDH1A1 722/4885CYP3A4 1179/4885 |
| US-11795174-B2 | Anti-pain compound and preparation method thereof | OPRK1, OPRM1, OPRL1 | TSHR 1955/4885ALDH1A1 1216/4885CYP3A4 382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.